Clinical Trial

Efficacy of Transverse Maxillary Expansion With AMCOP Preformed Appliances

Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated April 16, 2025 (before its estimated February 2026 completion). Its status may not reflect the trial's current state.
Summary
The present study aimed to investigate the cross-sectional effect of Class I AMCOP devices in patients of all possible skeletal types from both vertical skeletal pattern (normodivergent, hyperdivergent, hypodivergent) and sagittal skeletal pattern (skeletal Class I, skeletal Class II, skeletal Class III). The criterion for choosing patients was determined by the protocol of using these devices, which is to always perform an AMCOP First Class phase with the aim of improving transverse coordination of the arches, Spee's Curve and Wilson's Curve.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-03-03; most recent amendment 2025-04-15.
Status change: Recruiting → Enrolling by Invitation 2025-04-15
Status change: Not Yet Recruiting → Recruiting 2025-03-09
Trial Details
NCT Number NCT06864949
Lead Sponsor University of Pavia
Conditions Transverse Maxillary Deficiency
Enrollment 30 participants
Start Date 2025-03-15
Primary Completion 2026-02 (estimated)
Study Completion 2026-02 (estimated)
Updated on ClinicalTrials.gov 2025-04-16